Last reviewed · How we verify

NCT07499817

Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes

Recruiting now Phase 3 Last updated 30 March 2026
What this trial tests

Phase 3 trial testing pentoxifylline 400 mg in Embryo Transfer in 100 participants. Currently enrolling.

Timeline
1 October 2023
Primary endpoint
1 April 2026
30 April 2026

Quick facts

Lead sponsorBeni-Suef University
PhasePhase 3
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date1 October 2023
Primary completion1 April 2026
Estimated completion30 April 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 18 to 43, female only, with Embryo Transfer or IVF. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this work was to investigate the effect of different vasodilators as pentoxifylline in women with unexplained infertility using IVF

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Embryo Transfer

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07499817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing